Coya Therapeutics Profit Margin

The latest profit margin for COYA is -59.84% as of June 2026. That compares with -1442718.64% in the prior-year period — up 100.0% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside Coya Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, COYA's profit margin moved from -1442718.64% to -59.84% — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Coya Therapeutics's valuation or profitability profile.

Against its sector companies, COYA currently prints -59.84% for profit margin, while the sector average sits near 13.09%. That is roughly 557.2% below the sector mean. Large gaps often invite a closer look at Coya Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Coya Therapeutics converts resources into returns. At -59.84%, COYA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1442718.64% in the prior-year period — up 100.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting COYA's profit margin (-59.84%), review year-over-year change from -1442718.64%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.